Table 3.
The baseline characteristics of patients with L-PFT and H-PFT in the follow-up study.
| L-PFT (n = 41) | H-PFT (n = 177) | P | |
|---|---|---|---|
| Gender (M/F) | 21/20 | 122/55 | 0.032 |
| Age (years) | 19 (53–68) | 57 (48–66) | 0.140 |
| Diabetes course (years) | 4 (1–10) | 5 (1–14) | 0.214 |
| Hypertension (n, %) | 25, 61.0 | 102, 57.6 | <0.001 |
| BMI (kg/m2) | 23.70 (20.70–28.65) | 24.41 (21.52–27.37) | 0.581 |
| HbA1C (%) | 9.50 (7.35–11.00) | 8.30 (6.90–10.40) | 0.110 |
| FPG (mmol/L) | 8.41 (6.16–12.62) | 7.94 (5.99–10.88) | 0.544 |
| UACR (mg/g) | 13.80 (9.53–21.48) | 17.04 (12.58–21.01) | 0.184 |
| UTP (g/24 h) | 0.07 ± 0.04 | 0.08 ± 0.02 | 0.561 |
| ALB (g/L) | 39.90 (37.25–42.60) | 40.50 (37.65–44.15) | 0.362 |
| Urea (mmol/L) | 5.86 (4.56–6.95) | 5.90 (4.66–7.00) | 0.401 |
| SCr (μmol/L) | 70.00 (53.6–95.2) | 72.00 (55.0–105.5) | 0.412 |
| UA (μmol/L) | 334.66 ± 112.35 | 338.30 ± 129.23 | 0.868 |
| Tch (mmol/L) | 3.35 (2.03–4.62) | 3.92 (2.22–5.22) | 0.103 |
| TG (mmol/L) | 2.28 (1.09–4.07) | 2.53 (1.48–4.29) | 0.247 |
| HDL (mmol/L) | 1.06 (0.83–1.26) | 1.01 (0.85–1.28) | 0.897 |
| LDL (mmol/L) | 2.27 (1.95–3.09) | 2.63 (2.04–3.17) | 0.338 |
| eGFR (mL/min/1.73 m2) | 104.40 (80.0–112.5) | 105.34 (86.6–113.9) | 0.630 |
| Rx | |||
| None (diet alone) (n, %) | 3 (8.0) | 15 (8.3) | 0.285 |
| OHA (n, %) | 8 (19.8) | 37 (21.0) | 0.345 |
| Insulin ± OHA (n, %) | 24 (58.5) | 102 (57.5) | 0.114 |
| Antihypertensive drugs (n, %) | 15 (36.2) | 63 (35.4) | 0.186 |
| ACE-I/ARBs (n, %) | 9 (22.1) | 38 (21.5) | 0.201 |
| Hypolipidemic therapy (n, %) | 14 (34.0) | 59 (33.5) | 0.215 |
| PFT (cm) | 0.73 ± 0.15 | 1.34 ± 0.31 | <0.001 |
L-PFT: lower PFT group; H-PFT: higher PFT group; BMI: body mass index; hypertension: proportion of patients with hypertension; HbA1C: glycated hemoglobin ratio; FPG: fasting plasma glucose; UTP: total 24-hour urinary protein; UACR: urinary creatinine protein ratio; ALB: serum albumin; urea: serum urea nitrogen; SCr: blood creatinine; UA: blood uric acid; Tch: total serum cholesterol; TG: triglycerides; HDL: serum high-density lipoprotein; LDL: serum low-density lipoprotein; eGFR: predicted glomerular filtration rate; PFT: perirenal fat thickness; OHA: oral hypoglycemic agent; Rx: prescription.